Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Noladin ether (2-Arachidonyl glycerol ether) is a stable analog of the endogenous cannabanoid 2-Arachidonylglycerol (2-AG) with selectivity for CB1 receptors. Noladin ether is a CB1 agonist. The Ki values for CB1 vs CB2 receptors are 21.2 nM and 3 mM, respectively. Noladin ether induces sedation and has modest antinociceptive activity in vivo, and reduces inter ocular pressure after administration in the eye.
2-Arachidonyl glycerol ether (2-AG ether) is supplied as a solution in ethanol. To change the solvent, simply evaporate the ethanol under a gentle stream of nitrogen and immediately add the solvent of choice. Solvents such as DMSO and dimethyl formamide purged with an inert gas can be used.
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Endocannabinoids |
| Subclass | Not available |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Endocannabinoids |
| Alternative Parents | Monoalkylglycerols Glycerol ethers Dialkyl ethers Primary alcohols Hydrocarbon derivatives |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | 2-arachidonylglyceryl-ether-skeleton - Monoalkylglycerol - Monoradylglycerol - Glycerolipid - Glycerol ether - Ether - Dialkyl ether - Organic oxygen compound - Hydrocarbon derivative - Primary alcohol - Organooxygen compound - Alcohol - Aliphatic acyclic compound |
| Description | This compound belongs to the class of organic compounds known as endocannabinoids. These are arachidonic acid derivatives containing either an N-acetylethanolamine(type 1) or a glycerol(types 2 and 3) moiety attached to the aliphatic tail. |
| External Descriptors | Monoacylglycerols |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Oct 30, 2026 | N276283 | |
| Certificate of Analysis | Mar 18, 2026 | N276283 | |
| Certificate of Analysis | Jun 14, 2024 | N276283 | |
| Certificate of Analysis | May 22, 2024 | N276283 |
| Solubility | Soluble in DMSO to 100 mM and in ethanol to 50 mM |
|---|---|
| Molecular Weight | 364.600 g/mol |
| XLogP3 | 5.700 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 18 |
| Exact Mass | 364.298 Da |
| Monoisotopic Mass | 364.298 Da |
| Topological Polar Surface Area | 49.700 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 379.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 4 |
| Covalently-Bonded Unit Count | 1 |
No vendor-validated protocols are provided for this item. The following are general, non-binding examples to help plan pilot studies; adjust to your system and validate experimentally.
Example A: Stock preparation (cell-based assays)
Example B: Dosing into culture medium
Example C: Membrane binding/biochemical assays
Note
General background (literature; no therapeutic claims)
Caveats
This section summarizes literature knowledge only; consult primary sources for specific potency/efficacy data.
This compound is a hydrophobic research ligand, not a buffering agent. It does not form conventional buffer systems.
Practical note (general)
Context
Greener handling choices (general guidance)
Illustrative comparison (general)
Note
No pharmacopoeial or excipient role is specified for this item; it is sold strictly for research use only.
General research/formulation context (non-clinical, literature)
Compliance note
Item-specific (from Product Data)
Literature/general characteristics of noladin ether and similar long-chain polyunsaturated glycerol ethers
Not provided for this item (refer to CoA/Spec Sheet)
Practical notes
Item-specific (from Product Data)
What Moligand™ typically implies (general explanation)
How to use this information in practice
Documentation and traceability
This product is primarily used as a research ligand rather than a bulk reaction solvent or reagent. Accordingly, synthetic reaction applications are limited. Relevant use-cases include (literature/general):
Note: For general organic reactions on noladin ether, pre-dry solvents, degas, and operate under nitrogen/argon. Monitor reactions by LC–MS with soft ionization to minimize in-source oxidation artifacts.
Because noladin ether is typically used as a ligand, not a general reagent, there are no standardized “reaction conditions” for its use. The following are literature-style guidelines for common transformations on related polyunsaturated glycerol ethers; adapt as needed and validate experimentally.
Representative transformations (literature, general ranges)
Handling conditions (general)
Item-specific (from Product Data)
General safety guidance (defer to SDS for authoritative instructions)
Note: Always consult the product’s SDS and your institutional EHS policies before use.
General guidance for noladin ether (literature-based)
Quick comparison (general)
Note: Optimize solvent choice to your assay constraints and confirm by small-scale pilot tests.
Item-specific (from Product Data)
General best practices for this compound class
Not specified for this item; refer to CoA/Spec Sheet
Item-specific (from Product Data)
General structural description (literature)
Notes
General chemical reactivity (literature)
Analytical considerations
Workflow tip
Item-specific, tested biological targets or binding data are not provided for this product.
Literature/general context
For authoritative, product-specific target data (e.g., EC50/IC50, selectivity panels), consult the primary literature and perform in-house validation with appropriate positive/negative controls.
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →